Controlled nitric oxide delivery platform based on S-nitrosothiol conjugated interpolymer complexes for diabetic wound healing

Molecular Pharmaceutics

Volumn 7, Issue 1, 2010, Pages 254-266

  Li, Yan ^a   Lee, Ping I ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Controlled release; Diabetic wound healing; Interpolymer complex; Nitric oxide; S nitrosothiols

Indexed keywords

GLUTATHIONE; NITRIC OXIDE; ONTO POLY(VINYL METHYL ETHER CO MALEIC ANHYDRIDE); PHYTOCHELATIN; POVIDONE; S NITROSOTHIOL; UNCLASSIFIED DRUG;

ACCELERATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPLEX FORMATION; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DECOMPOSITION; DIABETES MELLITUS; DISULFIDE BOND; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG STABILITY; DRUG SYNTHESIS; EXPERIMENTAL MODEL; HYDROGEN BOND; IN VITRO STUDY; INFRARED SPECTROSCOPY; LIGHT EXPOSURE; MALE; NONHUMAN; PRIORITY JOURNAL; RAMAN SPECTROMETRY; RAT; SOLID STATE; TEMPERATURE SENSITIVITY; TIME PERCEPTION; WOUND CLOSURE; WOUND HEALING;

ANIMALS; DIABETES COMPLICATIONS; DIABETES MELLITUS, EXPERIMENTAL; DRUG DELIVERY SYSTEMS; DRUG STABILITY; GLUTATHIONE; MALE; MALEATES; MOLECULAR STRUCTURE; NITRIC OXIDE DONORS; PHYTOCHELATINS; POLYETHYLENES; RATS; RATS, SPRAGUE-DAWLEY; S-NITROSOTHIOLS; WOUND HEALING;

EID: 76249131110     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp900237f     Document Type: Article

References (59)

1. Barbato, J. E.; Tzeng, E. Nitric oxide and arterial disease. J. Vasc. Surg. 2004, 40, 187-193.
2. Toda, N.; Okamura, T. The pharmacology of nitric oxide in the peripheral nervous system of blood vessels. Pharmacol. Rev. 2003, 55, 271-324.
3. Taylor, E. L.; Megson, I. L.; Haslett, C.; Rossi, A. G. Nitric oxide: a key regulator of myeloid inflammatory cell apoptosis. Cell Death Differ. 2003, 10, 418-430.
4. Groves, P. H.; Banning, A. P.; Penny, W. J.; Newby, A. C. The effects of exogenous nitric-oxide on smooth-muscle cell-proliferation following porcine carotid angioplasty. Cardiovasc. Res. 1995, 30, 87-96.
5. Ricciardolo, F. L. M.; Sterk, P. J.; Gaston, B.; Folkerts, G. Nitric oxide in health and disease of the respiratory system. Physiol. Rev. 2004, 84, 731-765.
6. Wei, D. Y.; Richardson, E. L.; Zhu, K. Y.; Wang, L. W.; Le, X. D.; He, Y. J.; Huang, S. Y.; Xie, K. P. Direct demonstration of negative regulation of tumor growth and metastasis by hostinducible nitric oxide synthase. Cancer Res. 2003, 63, 3855-3859.
7. Ghavari, A.; Miller, C. C.; McMullin, B.; Ghahary, A. Potential application of gaseous nitric oxide as a topical antimicrobial agent. Nitric Oxide 2006, 14, 21-29.
8. Witte, M. B.; Barbul, A. Role of nitric oxide in wound repair. Am. J. Surg. 2002, 183, 406-412.
9. Isenberg, J. S.; Ridnour, L. A.; Espey, M. G.; Wink, D. A.; Roberts, D. D. Nitric oxide in wound- healing. Microsurgery 2005, 25, 442-451.
10. Schaffer, M. R.; Tantry, U.; Efron, P. A.; Ahrendt, G. M.; Thornton, F. J.; Barbul, A. Diabetes-impaired healing and reduced wound nitric oxide synthesis: a possible pathophysiologic correlation. Surgery 1997, 121, 513-519.
11. Witte, M. B.; Kiyama, T.; Barbul, A. Nitric oxide enhances experimental wound healing in diabetes. Br. J. Surg. 2002, 89, 1594-1601.
12. Ignarro, L. J. Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu. Rev. Pharmacol. Toxicol. 1990, 30, 535-560.
13. Wang, P. G.; Cai, T. B. Nitric Oxide Donors; Taniguchi, N., Eds.; Wiley-VCH: Weinheim, 2005.
14. Wang, P. G.; Xian, M.; Tang, X.; Wu, X.; Wen, Z.; Cai, T.; Janczuk, A. J. Nitric oxide donors: chemical activities and biological applications. Chem. Rev. 2002, 102, 1091-1134.
15. Napoli, C.; Ignarro, L. J. Nitric oxide-releasing drugs. Annu. Rev. Pharmacol. Toxicol. 2003, 43, 97-123.
16. Miller, M. R.; Megson, I. L. Recent development in nitric oxide donor drugs. Br. J. Pharmacol. 2008, 151, 305-321.
17. Smith, D. J.; Chakravarthy, D.; Pulfer, S.; Simmons, M. L.; Hrabie, J. A.; Citro, M. L.; Saavedra, J. E.; Davies, K. M.; Hutsell, T. C.; Mooradian, D. L.; Hanson, S. R.; Keefer, L. K. Nitric oxidereleasing polymers containing the [N(O)NO]- group. J. Med. Chem. 1996, 39, 1148-1156.
18. Batchelor, M. M.; Reoma, S. L.; Fleser, P. S.; Nuthakki, V. K.; Callahan, R. E.; Shanley, C. J.; Politis, J. K.; Elmore, J.; Merz, S. I.; Meyerhoff, M. E. More lipophilic dialkyldiamine-based diazeniumdiolates: synthesis, characterization, and application in preparing thromboresistant nitric oxide release polymeric coatings. J. Med. Chem. 2003, 46, 5153-5161.
19. Zhou, Z.; Meyerhoff, M. E. Preparation and characterization of polymeric coatings with combined nitric oxide release and immobilized active heparin. Biomaterials 2005, 26, 6506-6517.
20. Kröncke, K. D.; Suschek, C. V. Adulterated effect of nitric oxidegenerating donors. J. Invest. Dermatol. 2008, 128, 258-260.
21. Bauer, J. A.; Rao, W.; Smith, D. J. Evaluation of linear polyethyleneimine/nitric oxide adduct on wound repair: therapy versus toxicity. Wound Rep. Reg. 1998, 6, 569-577.
22. Arnold, E. V.; Doletski, B. G.; Raulli, R. E. Nitric oxide-releasing molecules. International Patent Application No. PCT/US05/ 000174.
23. http://home.ncifcrf.gov/lcc/nitricoxide/NOdonors.asp.
24. http://www.amuletpharma.com/techplatforms.html.
25. Richardson, G.; Benjamin, N. Potential therapeutic uses for S-nitrosothiols. Clin. Sci. 2002, 102, 99-105.
26. Williams, D. L. H. The mechanism of nitric oxide formation from S-nitrosothiols (thionitrites). Chem. Commun. 1996, 10, 1085-1091.
27. Roy, B.; dïHardemare, A. D.; Fontecave, M. New thionitrites: synthesis, stability, and nitric oxide generation. J. Org. Chem. 1994, 59, 7019-7026.
28. Lu, D.; Nadas, J.; Zhang, G.; Johnson, W.; Zweier, J. L.; Cardounel, A. J.; Villamena, F. A.; Wang, P. G. 4-Aryl-1,3,2-oxathiazolylium-5-olates as pH-controlled NO-donors: the next generation of S-nitrosothiols. J. Am. Chem. Soc. 2007, 129, 5503-5514.
29. Katsumi, H.; Nishikawa, M.; Ma, S. F.; Yamashita, F.; Hashida, M. Physicochemical, tissue distribution, and vasodilation characteristics of nitrosated serum albumin: delivery of nitric oxide in vivo. J. Pharm. Sci. 2004, 93, 2343-2352.
30. Katsumi, H.; Nishikawa, M.; Yamashita, F.; Hashida, M. Development of polyethylene glycol-conjugated poly-S-nitrosated serum albumin, a novel S-nitrosothiol for prolonged delivery of nitric oxide in the blood circulation in vivo. J. Pharmacol. Exp. Ther. 2005, 314, 1117-1124.
31. Seabra, A. B.; Da Rocha, L. L.; Eberlin, M. N.; de Oliveira, M. G. Solid films of blended poly(vinyl alcohol)/poly(vinyl pyrrolidone) for topical S-nitrosoglutathione and nitric oxide release. J. Pharm. Sci. 2005, 94, 994-1003.
32. Shishido, S. M.; Seabra, A. B.; Loh, W.; de Oliveira, M. G. Thermal and photochemical nitric oxide release from S-nitrosothiols incorporated in Pluronic F127 gel: potential uses for local and controlled nitric oxide release. Biomaterials 2003, 24, 3543-3553.
33. Seabra, A. B.; Fitzpatrick, A.; Paul, J.; de Oliveira, M. G.; Weller, R. Topically applied S-nitrosothiol-containing hydrogels as experimental and pharmacological nitric oxide donors in human skin. Br. J. Dermatol. 2004, 151, 977-983.
34. Amadeu, T. P.; Seabra, A. B.; de Oliveira, M. G.; Costa, A. M. A. S-Nitrosoglutathione-containing hydrogel accelerates rat cutaneous wound repair. J. Eur. Acad. Dermatol. Venereol. 2007, 21, 629-637.
35. Bohl, K. S.; West, J. L. N itric oxide-generating polymers reduce platelet adhesion and smooth muscle cell proliferation. Biomaterials 2000, 21, 2273-2278.
36. Seabra, A. B.; da Silva, R.; de Oliveira, M. G. Polynitrosated polyesters: preparation, characterization, and potential use for topical nitric oxide release. Biomacromolecules 2005, 6, 2512-2520.
37. Jiang, M.; Li, M.; Xiang, M.; Zhou, H. Interpolymer complexation and miscibility enhancement by hydrogen bonding. Adv. Polym. Sci. 1999, 146, 121-196.
38. Rauser, W. E. Phytochelatins and related peptides: structure, biosynthesis, and function. Plant Physiol. 1995, 109, 1141-1149.
39. Pinaud, F.; King, D.; Moore, H. P.; Weiss, S. Bioactivation and cell targeting of semiconductor CdSe/ZnS nanocrystals with phytochelatin-related peptides. J. Am. Chem. Soc. 2004, 126, 6115-6123.
40. http://www.ushio.com/files/specs/Ultra8T8UBend.pdf.
41. Frost, M. C.; Meyerhoff, M. E. Controlled photoinitiated release of nitric oxide from polymer films containing S-nitroso-N-acetyl- DL-penicillamine derivatized fumed silica filler. J. Am. Chem. Soc. 2004, 126, 1348-1349.
42. Mowery, K. A.; Schoenfisch, M. H.; Saavedra, J. E.; Keefer, L. K.; Meyerhoff, M. E. Preparation and characterization of hydrophobic polymeric films that are thromboresistant via nitric oxide release. Biomaterials 2000, 21, 9-21.
43. Nims, R.; Cook, J.; Krishna, M.; Christodoulou, D.; Poore, C.; Miles, A.; Grisham, M.; Wink, D. Colorimetric assays for nitric oxide and nitrogen oxide species formed from nitric oxide stock solutions and donor compounds. Methods Enzymol. 1996, 268, 93-105.
44. Butler, P. J. G.; Harris, J. I.; Hartley, B. S.; Leberman, R. Use of maleic anhydride for reversible blocking of amino groups in polypeptide chains. Biochem. J. 1969, 112, 679-689.
45. Ladavière, C.; Lorenzo, C.; Elaïssari, A.; Mandrand, B.; Delair, T. Electrostatically driven immobilization of peptides onto (maleic anhydride-alt-methyl vinyl ether) copolymers in aqueous media. Bioconjugate Chem. 2000, 11, 146-152.
46. Allard, L.; Cheynet, V.; Oriol, G.; Mandrand, B.; Delair, T.; Mallet, F. Versatile method for production and controlled polymerimmobilization of biologically active recombinant proteins. Biotechnol. Bioeng. 2002, 80, 341-348.
47. Khutoryanskiy, V. V. Hydrogen-bonded interpolymer complexes as materials for pharmaceutical applications. Int. J. Pharm. 2007, 334, 15-26.
48. Haddadine-rahmoun, N.; Amrani, F.; Arrighi, V.; Cowie, J. M. G. Interpolymer complexation in hydrolysed poly(styrene-co-maleic anhydride)/poly(styrene-co-4-vinylpyridine). Eur. Polym. J. 2008, 44, 821-831.
49. Lee, J. Y.; Painter, P. C.; Colman, M. M. Hydrogen bonding in polymer blends. 3. Blends involving polymers containing methacrylic acid and ether groups. Macromolecules 1988, 21, 346-354.
50. Xu, X.; Lee, P. I. Programmable drug delivery from an erodible association polymer system. Pharm. Res. 1993, 10, 1144-1152.
51. Williams, D. L. H. The chemistry of S-nitrosothiols. Acc. Chem. Res. 1999, 32, 869-876.
52. Sextona, D. L.; Ruganandadmo, R.; Mckenney, N. J.; Mutus, B. Visible light photochemical release of nitric oxide from Snitrosoglutathione: Potential photochemotherapeutic applications. Photochem. Photobiol. 1994, 59, 463-461.
53. Wood, P. D.; Mutus, B.; Redmond, R. W. The Mechanism of Photochemical Release of Nitric Oxide from S-Nitrosoglutathione. Photochem. Photobiol. 1996, 64, 518-524.
54. Stasko, N. A.; Fischer, T. H.; Schoenfisch, M. H. S-Nitrosothiolmodified dendrimers as nitric oxide delivery vehicles. Biomacromolecules 2008, 9, 834-841.
55. Picquart, M.; Grajcar, L.; Baron, M. H.; Abedinzadeh, Z. Vibrational spectroscopic study of glutathione complexation in aqueous solutions. Biospectroscopy 1999, 5, 328-337.
56. Brandt, N. N.; Chikishev, A. Y.; Kargovsky, A. V.; Nazarov, M. M.; Parashchuk, O. D.; Sapozhnikov, D. A.; Smirnova, I. N.; Shkurinov, A. P.; Sumbatyan, N. V. Terahertz time-domain and raman spectroscopy of the sulfur-containing peptide dimers: lowfrequency markers of disulfide bridges. Vib. Spectrosc. 2008, 47, 53-58.
57. Grossi, L.; Montevecchi, P. C. A kinetic study of S-nitrosothiol decomposition. Chem. Eur. J. 2002, 8, 380-387.
58. Noble, D. R.; Williams, D. L. H. Structure-reactivity studies of the Cu2+-catalyzed decomposition of four S-nitrosothiols based around the S-nitrosocysteine/S-nitrosoglutathione structures. Nitric Oxide 2000, 4, 392-398.
59. Hogg, N. Biological chemistry and clinical potential of Snitrosothiols. Free Radical Biol. Med. 2000, 28, 1478-1486.